FindTrial
Sign In

Randomized, Double-blind, Multicenter study to compare the safety and efficacy of Viramidine to Ribavirin in Treatment-Naive patients with Chronic Hepatitis C

Randomized, Double-blind, Multicenter study to compare the safety and efficacy of Viramidine to Ribavirin in Treatment-Naive patients with Chronic Hepatitis C

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-000408-41-IT
Enrollment
Unknown
Registered
2005-06-28
Start date
2004-09-28
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis C MedDRA version: 6.1 Level: PT Classification code 10019744

Interventions

Product Name: Viramidine Product Code: RNA003142 Pharmaceutical Form: Film-coated tablet CAS Number: 40372-00-7 Current Sponsor code: RNA003142 Concentration unit: mg milligram(s) Concentration type:

Sponsors

RIBAPHARM
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026